Treatment strategies for advanced hepatocellular carcinoma: Sorafenib hepatic arterial infusion chemotherapy

about

Treatment strategies for advanced hepatocellular carcinoma: Sorafenib hepatic arterial infusion chemotherapy

Item

http://www.wikidata.org/entity/Q57491231

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Treatment strategies for advan ...... arterial infusion chemotherapy

@en

Treatment strategies for advan ...... arterial infusion chemotherapy

@nl

type

Item

label

Treatment strategies for advan ...... arterial infusion chemotherapy

@en

Treatment strategies for advan ...... arterial infusion chemotherapy

@nl

prefLabel

Treatment strategies for advan ...... arterial infusion chemotherapy

@en

Treatment strategies for advan ...... arterial infusion chemotherapy

@nl

P1476

Treatment strategies for advan ...... arterial infusion chemotherapy

@en

P2093

Isao Hidaka

http://www.w3.org/2001/XMLSchema#string

Isao Sakaida

http://www.w3.org/2001/XMLSchema#string

Issei Saeki

http://www.w3.org/2001/XMLSchema#string

Koichi Fujisawa

http://www.w3.org/2001/XMLSchema#string

Masaki Maeda

http://www.w3.org/2001/XMLSchema#string

Naoki Yamamoto

http://www.w3.org/2001/XMLSchema#string

Takahiro Yamasaki

http://www.w3.org/2001/XMLSchema#string

Takuro Hisanaga

http://www.w3.org/2001/XMLSchema#string

Takuya Iwamoto

http://www.w3.org/2001/XMLSchema#string

Taro Takami

http://www.w3.org/2001/XMLSchema#string

P2860

Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?

JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan

Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma

Management of hepatocellular carcinoma: An update

Sorafenib in advanced hepatocellular carcinoma

2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Hepatocellular carcinoma

Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma.

Intra-arterial therapy with cisplatin suspension in lipiodol and 5-fluorouracil for hepatocellular carcinoma with portal vein tumour thrombosis.

P304

571-584

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4254/WJH.V10.I9.571

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30310535

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

6177565

http://www.w3.org/2001/XMLSchema#string